Consensus Statement: Chromosomal Microarray Is a First-Tier Clinical Diagnostic Test for Individuals with Developmental Disabilities or Congenital Anomalies

David T. Miller(Boston Children's Hospital), Margaret P Adam(Emory University), Swaroop Aradhya, Leslie G. Biesecker(National Institutes of Health), Arthur R. Brothman(University of Utah), Nigel P. Carter(Wellcome Sanger Institute), Deanna M. Church(National Center for Biotechnology Information), John A. Crolla(Wessex Regional Genetics Laboratory), Evan E. Eichler(Howard Hughes Medical Institute), Charles J. Epstein(University of California, San Francisco), W. Andrew Faucett(Emory University), Lars Feuk(Uppsala University), Jan M. Friedman(University of British Columbia), Ada Hamosh(Johns Hopkins University), Laird Jackson(Children's Hospital of Philadelphia), Erin B. Kaminsky(Emory University), Klaas Kok(University Medical Center Groningen), Ian D. Krantz(Children's Hospital of Philadelphia), Robert M. Kuhn(University of California, Santa Cruz), Charles Lee(Brigham and Women's Hospital), James M. Ostell(National Center for Biotechnology Information), Carla Rosenberg, Stephen W. Scherer(University of Toronto), Nancy B. Spinner(Children's Hospital of Philadelphia), Dimitri J. Stavropoulos(Hospital for Sick Children), James Tepperberg(Triangle), Erik C. Thorland(Mayo Clinic in Arizona), Joris Vermeesch, Darrel Waggoner(University of Chicago), Michael S. Watson(American College of Medical Genetics), Christa Lese Martin(Emory University), David H. Ledbetter(Emory University)
The American Journal of Human Genetics
May 1, 2010
Cited by 2,868Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis